A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer

British Journal of Cancer

Volumn 94, Issue 6, 2006, Pages 828-834

  Jenkins, V ^a   Shilling, V ^a   Deutsch, G ^b   Bloomfield, D ^b   Morris, R ^a   Allan, S ^c   Bishop, H ^d   Hodson, N ^b   Mitra, S ^b   Sadler, G ^e   Shah, E ^e   Stein, R ^f   Whitehead, S ^e   Winstanley, J ^d  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^d ROYAL BOLTON HOSPITAL   (United Kingdom)

^e East Sussex Healthcare NHS Trust   (United Kingdom)

^f LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Chemotherapy; Cognitive dysfunction; Endocrine treatment

Indexed keywords

ANASTROZOLE; GOSERELIN; LETROZOLE; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGE DISTRIBUTION; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; COGNITION; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; ENDOCRINE DISEASE; FEMALE; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; MEMORY; MEMORY DISORDER; MENOPAUSE; MENTAL CONCENTRATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; SELF REPORT; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; FEMALE; HUMANS; INTELLIGENCE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; STRESS, PSYCHOLOGICAL;

EID: 33645327413     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603029     Document Type: Article

References (27)

1. Bender C, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM (2005) Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-oncology, Aug 12 [Epub ahead of print]
2. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G (1997) Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 15: 974-986
3. Broadbent D, Cooper PF, FitzGerald P, Parkes KR (1982) The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 21 (Part 1): 1-16
4. Burgess C, Ramirez A, Cornelius V, Love S, Graham J, Richards M (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330: 702-705
5. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA (2005) The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 59: 60-70
6. Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D (1999) Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT- B. Breast Cancer Res Treat 55: 189-199
7. Goldberg D, Williams P (1988) A User's Guide to the General Health Questionnaire. Windsor: NFER-Nelson
8. Golden CJ (1978) Stroop Colour and Word Test. Chicago: Stoelting Co
9. Jacobson NS, Truax P (1991) Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59: 12-19
10. Jenkins V, Shilling V, Fallowfield LJ, Howell A, Hutton S (2004) Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? Psycho-Oncology 13: 61-66
11. Kneebone AC, Andrew MJ, Baker RA, Knight JL (1998) Neuropsychologic changes after coronary artery bypass grafting: use of reliable change indices. Ann Thorac Surg 65: 1320-1325
12. McAllister TW, Ahles TA, Saykin AJ, Ferguson RJ, McDonald BC, Lewis LD, Flashman LA, Rhodes CH (2004) Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments. Curr Psychiatry Rep 6: 364-371
13. Nelson H (1991) National Adult Reading Test (NART) Manual. NFER-NELSON
14. Paganini-Hill A, Clark LJ (2000) Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64: 165-176
15. Rey A (1941) Psychological examination of traumatic encephalopathy. Arch Psychol 28: 286-340
16. Rey A (1964) L'Examen clinique en psychologie.. Paris: Presses Universitaires de France
17. Sawrie SM, Chelune GJ, Naugle RI, Luders HO (1996) Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery. J Int Neuropsychol Soc 2: 556-564
18. Schagen SB, Muller MJ, Boogerd W, Van Dam FS (2002) Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective. Clin Breast Cancer 3(Suppl 3): S100-S108
19. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D (2005a) The effects of adjuvant chemotherapy on cognition in women with breast cancer-preliminary results of an observational longitudinal study. Breast 14: 142-150
20. Shilling V, Jenkins V, Trapala IS (2005b) The (mis)classification of chemofog - methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 1-5, Oct 27 [Epub ahead of print]
21. Taylor L (1979) Psychological assessment of neurosurgical patients. In Functional Neurosurgery Marino TRAR (ed) New York: Raven Pres
22. Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21: 4175-4183
23. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90: 210-218
24. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100: 2292-2299
25. Weschler D (1998) The Weschler Memory Scale-Revised Vol. 3, (edn).
26. Wieneke M, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology 4: 61-66
27. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13: 63-74